Navigation Links
Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules
Date:7/8/2008

MAIDENHEAD, England, July 8 /PRNewswire-FirstCall/ --

- PREVENAR Vaccine to Help Protect Children Against the Leading Vaccine-Preventable Cause of Death in Young Children

Wyeth applauds the countries of Cyprus, Hungary, the Kingdom of Bahrain, Republic of Ireland, Slovak Republic and Sweden for announcing their decisions to routinely immunize infants and young children against pneumococcal disease by adding PREVENAR(TM) PCV7 (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed) to their national immunization programs(1). This announcement makes it 24 countries across the world that have now included Prevenar in their immunizations schedules(1).

"We share these countries' commitment to protecting children from the potentially devastating effects of pneumococcal disease and applaud the swift action they have taken in addressing this urgent and pressing health issue," says Bernard Fritzell, Vice President, International Scientific & Clinical Affairs, Wyeth Vaccines Research, in Paris, France. "Wyeth is dedicated to the wellbeing of children and to working with other governments and agencies to further expand the access to Prevenar. This includes accelerating the introduction of the vaccine in those countries that have announced their decision to incorporate Prevenar in their National Immunisation Programmes but have yet to introduce the vaccine as part of their immunization schedule."

This is important news as pneumococcal disease results in 1.6 million deaths per year worldwide, of which up to 1 million deaths are in children younger than five years of age(2). Pneumococcal disease is the leading vaccine-preventable cause of death in children younger than five years of age worldwide(3).

"Specifically, since the introduction of PCV7, into Germany's paediatric immunization schedule in 2006, there has been a 50 percent reduction in vaccine-type invasive pneumococcal disease (IPD) in children younger than 2 years old compared with
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
2. Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
3. Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
4. Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers
5. Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis
6. Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
7. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
8. Wyeths TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
9. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
10. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
11. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... RAPIDS, Mich. , Jan. 15, 2014 As health ... the flu virus, select Meijer pharmacies in Michigan ... strep throat to eligible patients, enabling Meijer pharmacists to administer ... strict protocol set by a physician participating in the study. ...
(Date:1/15/2014)... , January 15, 2014 Shire plc (LSE: SHP, ... Office of Fair Trading (OFT) approval condition to the announced tender ... VPHM).   As a result of the waiver, the ... to complete the tender offer on January 24, 2014 following the ...
(Date:1/15/2014)... is very pleased to announce the appointment of Mr. ... Mark was promoted from his current role of Chief Operating ... in Massachusetts , Mississippi ... 2012 with 20+ years of broad-based operations, sales, engineering and ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... May 11, 2011 Chimerix, Inc., a pharmaceutical ... showing that the majority of immunocompromised patients with ... lead antiviral compound, CMX001, had a > 99% ... two weeks of therapy.  These CMX001 clinical data, ...
... AUSTIN, Texas, May 11, 2011 HCB Health, one ... the nation and the leading healthcare agency in the ... campaign in the 22nd annual Manny Awards, a national ... was presented for a consumer campaign supporting Sound Surgical ...
Cached Medicine Technology:CMX001 Shows Antiviral Activity in Immunocompromised Transplant Patients With Severe Adenovirus Infection 2CMX001 Shows Antiviral Activity in Immunocompromised Transplant Patients With Severe Adenovirus Infection 3HCB Health Wins Manny Award for Best Medical Device Campaign 2
(Date:4/18/2014)... Medicine scientists could lead to potential new treatments for ... scleroderma. , Fibrosis, or scarring, is a hallmark ... and lungs can lead to serious organ damage and, ... therapeutic options centers on findings made by Swati Bhattacharyya, ... role that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... specifically associated with the risk of a difficult-to-diagnose ... of all breast cancer cases. , The largest ... invasive lobular carcinoma, gives researchers important clues to ... breast cancer, which can be missed through screening. ... journal PloS Genetics , was co-led by ...
(Date:4/17/2014)... study published today in PLOS Pathogens , children ... is common can mount an immune response to infection ... repeated bouts of high fever and illness and partially ... The findings may help researchers develop future interventions that ... parasite. , Each year, approximately 200 million cases of ...
(Date:4/17/2014)... (April 17, 2014) Two recent papers by ... and colleagues may help scientists develop treatments or ... fever, Japanese encephalitis and other disease-causing flaviviruses. , ... and molecular genetics at the School of Medicine ... Hughes Medical Institute, and colleagues recently published articles ...
(Date:4/17/2014)... team has created a new technology for modifying ... travel the body and selectively target cancer and ... devices that monitor and modify human physiology is ... no existing technology enabled bioengineers to build such ... respond in a customized fashion. , "The project ...
Breaking Medicine News(10 mins):Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2Health News:Building 'smart' cell-based therapies 2
... , ALEXANDRIA, Va., Oct. 7 Catholic Charities USA ... assessment and response team to American Samoa to assist ... coordinate with FEMA and other agencies in providing relief ... of the earthquake and tsunami devastation. , (Logo: ...
... Ancient Hamar Tribe Adopts Sustainable Hygiene and Water Programs ... ISLAND, Wash., Oct. 7 Northwest-based nonprofit Global Team ... grant by US Agency for International Development (USAID) to ... in Ethiopia. Since 2008, GTLI, which incubated a ...
... PRXL ) will release First Quarter Fiscal Year 2010 financial ... stock market. The announcement will be available on PAREXEL,s website ... website at www.prnewswire.com . , PAREXEL will host ... Wednesday, October 28, 2009 to discuss the results. To access ...
... This press release is available in French ... tourism in Latin America needs to be regulated to ... new study published in the journal Developing World ... marketing themselves to international health care consumers: these clinics ...
... are helping, but more is needed to stem teen obesity, ... in the United States are becoming healthier places thanks to ... still more is needed to combat teen obesity, a series ... studies, which appear in a September supplement to the ...
... The Ensign Group, Inc. (Nasdaq: ENSG ), announced ... facilities, South Valley Care Center in West Jordan, a ... Care Center in Provo, and Castle Country Care Center ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ) , "These strategic ...
Cached Medicine News:Health News:Catholic Charities USA Moves Disaster Response Team to American Samoa 2Health News:Global Team for Local Initiatives Awarded $387,000 by USAID: New Model for Indigenous Health in Ethiopia 2Health News:PAREXEL Announces Date of First Quarter Fiscal Year 2010 Earnings Release and Conference Call 2Health News:Study examines ethical dilemmas of medical tourism 2Health News:Nutrition Still Not 'A' Grade in U.S. Schools: Studies 2Health News:The Ensign Group Acquires Three Utah Skilled Nursing Facilities 2
... system builds on the basic infrastructure ... in the system are networked to ... Windows® operating system, which monitors system ... personal computer, RoamAlert Integrity provides reporting ...
... Awarix provides an enterprise visibility ... throughput, improve caregiver effectiveness, and increase ... edge RFID location systems and geospatial ... systems to create a real time ...
MONOJECT MAGELLAN Safety Blood Collection Needle...
This is adapted to microplate or card....
Medicine Products: